Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

盐酸芬氟拉明片 - NMPA Drug Approval Details

Approvals/NMPA/Fenfluramine Hydrochloride Tablets

Approved

化学药品

Fenfluramine Hydrochloride Tablets

江苏四环生物股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Sep 13, 2002
Approval ID: 7zyz4MxSaTA
Company: 江苏四环生物股份有限公司
Type: 化学药品

Approval Details

Approval Id: 7zyz4MxSaTA
Approval Number: 国药准字H32024120
Generic Name: 盐酸芬氟拉明片
Generic Name En: Fenfluramine Hydrochloride Tablets
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 20mg
Reg Date: 2002-09-13
Company Name: 江苏四环生物股份有限公司
Production Company Address: 江苏省江阴市滨江开发区定山路10号
Company Detail Path: /organization/jiansu-sihuan-bioengineering-co-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 13, 2002

Approval ID

7zyz4MxSaTA

Type

化学药品

Back to NMPA Approvals